Forge Biologics to Present at 40th Annual J.P. Morgan Healthcare Conference
COLUMBUS, Ohio--(BUSINESS WIRE)-- Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that Timothy J. Miller, Ph.D., CEO, President, and Co-Founder, will present at the 40th Annual J.P. Morgan Healthcare Conference virtually on Tuesday, January 11, 2022, at 10:00 a.m. Eastern Time.
The presentation will be available on the Events section of the Forge Biologics website (https://www.forgebiologics.com/news/#events) on January 11 and for 30 days following the event.
About Forge Biologics
Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea to reality. Forge has a 175,000 square foot facility in Columbus, Ohio, The Hearth, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. To learn more, visit www.forgebiologics.com
Marina Corleto, M.N.O.
Senior Manager, Marketing and Communications
Families and Clinician Inquiries
Maria Escolar, M.D., M.S.
Chief Medical Officer
Magdalena Tyrpien, M.B.A.
Senior Vice President, Head of Business Development
John Maslowski, M.S.
Chief Commercial Officer
Christina Perry, M.S.A., C.P.A.
Senior Vice President, Finance and Investor Relations
Source: Forge Biologics